Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Liver Cells, Insulin-producing Cells, Thymus… >
Liver Cells, Insulin-producing Cells, Thymus Can Be Grown in Lymph Nodes, Pitt Team Finds

Published: September 27, 2012.
By University of Pittsburgh Schools of the Health Sciences
http://www.upmc.com/Pages/default.aspx

PITTSBURGH, Sept. 27, 2012 – Lymph nodes can provide a suitable home for a variety of cells and tissues from other organs, suggesting that a cell-based alternative to whole organ transplantation might one day be feasible, according to researchers at the University of Pittsburgh School of Medicine and its McGowan Institute for Regenerative Medicine. In a report recently published online in Nature Biotechnology, the research team showed for the first time that liver cells, thymus tissue and insulin-producing pancreatic islet cells, in an animal model, can thrive in lymph nodes despite being displaced from their natural sites.

Hepatitis virus infection, alcoholic cirrhosis and other diseases can cause so much damage that liver transplantation is the only way to save the patient, noted senior investigator Eric Lagasse, Pharm. D., Ph.D., associate professor, Department of Pathology, Pitt School of Medicine. Children with DiGeorge syndrome lack functional thymus glands to produce essential immune cells, and diabetes can be cured with a pancreas transplant.

"However, the scarcity of donor organs means many people will not survive the wait for transplantation," said Dr. Lagasse, whose lab is at the McGowan Institute. "Cell therapies are being explored, but introducing cells into tissue already ravaged by disease decreases the likelihood of successful engraftment and restoration of function."

In the study, his team tested the possibility of using lymph nodes, which are abundant throughout the body and have a rich blood supply, as a new home for cells from other organs in what is called an "ectopic" transplant.

They injected healthy liver cells from a genetically-identical donor animal into lymph nodes of mice at various locations. The result was an enlarged, liver-like node that functioned akin to the liver; in fact, a single hepatized lymph node rescued mice that were in danger of dying from a lethal metabolic liver disease. Likewise, thymus tissue transplanted into the lymph node of mice that lacked the organ generated functional immune systems, and pancreatic islet cell transplants restored normal blood sugar control in diabetic animals.

"Our goal is not necessarily to replace the entire liver, for example, but to provide sufficient cell mass to stabilize liver function and sustain the patient's life," Dr. Lagasse said. "That could buy time until a donor organ can be transplanted. Perhaps, in some cases, ectopic cell transplantation in the lymph node might allow the diseased organ to recover."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

System 
6/28/13 
Dendritic Cell Therapy Improves Kidney Transplant Survival, Pitt Team Says
By University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, June 28, 2013 -- A single systemic dose of special immune cells prevented rejection for almost four months in a preclinical animal model of kidney transplantation, according to …
Cells 
1/17/14 
New Insights into Facial Transplantation
By Brigham and Women's Hospital
Boston, MA—In 2009, the first face transplant was performed at Brigham and Women's Hospital (BWH), and lead surgeon, Dr. Bohdan Pomahac has been pioneering the procedure since. However, understanding …
Transplant 
9/1/11 
New Half-match Bone Marrow Transplant Procedure Yields Promising Outcomes for Cancer Patients
By Thomas Jefferson University
PHILADELPHIA—Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center …
Transplantation 
9/15/10 
King's College London Reveals Promising Techniques for Extending the Life of an Organ Transplant
By King's College London
Experts from the Medical Research Council (MRC) Centre for Transplantation at King's College London, based at Guy's Hospital, have revealed exciting new scientific developments for people with an organ …
Lakkis 
5/15/13 
Pitt Transplant Experts Challenge Assumption, Describe Pathway That Leads to Organ Rejection
By University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, May 15, 2013 – Transplant researchers at the University of Pittsburgh School of Medicine challenge a long-held assumption about how biologic pathways trigger immune system rejection of donor …
Cells 
5/16/13 

Stem-cell-based Strategy Boosts Immune System in Mice
By University of California - San Francisco
Cells 
1/27/14 
Immune System Drives Pregnancy Complications After Fetal Surgery in Mice
By University of California - San Francisco
As a fetal surgeon at UC San Francisco, Tippi MacKenzie, MD, has long known that conducting surgery on a fetus to correct a problems such as spina bifida often …
Cells 
8/3/12 
Unexpected Variation in Immune Genes Poses Difficulties for Transplantation
By Cell Press
Human HLA genes – the genes that allow our immune system to tell the difference between our own cells and foreign invaders – are evolving much more rapidly than …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition